Rachael Susser

Rachael Susser is a highly experienced professional in the field of chemical engineering and drug substance development, currently serving as Director of Drug Substance MSAT at Keros Therapeutics since April 2023. Prior to this role, Rachael held various leadership positions at Magenta Therapeutics, including Director and Associate Director of Drug Substance Development and Manufacturing. Rachael's extensive background includes significant contributions at Takeda as Head of Business Operations for Global Manufacturing Sciences and as Staff Engineer in Technical Operations. Rachael's career began at ImmunoGen, Inc. and further includes research roles at prestigious institutions such as the Massachusetts Institute of Technology, the Feinstein Institute for Medical Research, and Columbia University in the City of New York. Rachael holds a Master's degree in Chemical Engineering from North Carolina State University and a Bachelor's degree from Columbia Engineering.